Infection-related hospital admissions after transrectal biopsy of the prostate

ANZ Journal of Surgery

Volumn 83, Issue 4, 2013, Pages 246-248

  Sanders, Andrew ^a   Buchan, Nicholas ^b,c  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b Urology Associates   (New Zealand)

^c St George's Medical Centre   (New Zealand)

Author keywords

Prostate biopsy; Prostate cancer; Sepsis

Indexed keywords

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BIOPSY; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MALE; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RETROSPECTIVE STUDY; STATISTICS; URINARY TRACT INFECTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; BIOPSY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PATIENT ADMISSION; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 84875922403     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/ans.12073     Document Type: Article

References (14)

1. Ministry of Health NZ. Cancer: selected sites 2008, 2009, and 2010. 2011.
2. Trabulsi E, Halpern E, Gomella LG. Ultrasonography and biopsy of the prostate. In: Wein A (ed.). Campbell-Walsh Urology, 10th edn. Saunders: Philadelphia, 2010; 2735-2747.
3. Nam RK, Saskin R, Lee Y etal. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J. Urol. 2010; 183: 963-968.
4. Puig J, Darnell A, Bermúdez P etal. Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary? Eur. Radiol. 2006; 16: 939-943.
5. European Association of Urology. 2012. Guidelines on prostate cancer.
6. Mosharafa AA, Torky MH, El Said WM, Meshref A. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Urology 2011; 78: 511-514.
7. Hori S, Sengupta A, Joannides A, Balogun-Ojuri B, Tilley R, McLoughlin J. Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: are we putting our patients at risk? BJU Int. 2010; 106: 1298-1302.
8. Ministry of Health NZ. Cancer: historical summary 1948-2008. 2011.
9. Ismail M, Saini A, Nigam R. Ciprofloxacin-resistant infection after transrectal ultrasonography-guided prostate biopsy: should we reassess our practice? BJU Int. 2011; 108: 305-306.
10. Zaytoun OM, Vargo EH, Rajan R, Berglund R, Gordon S, Jones JS. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology 2011; 77: 1035-1041.
11. Simsir A, Kismali E, Mammadov R, Gunaydin G, Cal C. Is it possible to predict sepsis, the most serious complication in prostate biopsy? Urol. Int. 2010; 84: 395-399.
12. Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schroder FH, Roobol MJ. Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur. Urol. 2012; 61: 1110-1114.
13. Akduman B, Akduman D, Tokgoz H etal. Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Urology 2011; 78: 250-255.
14. Williamson DA, Roberts SA, Paterson DL etal. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. Clin. Infect. Dis. 2012; 54: 1406-1412.